Loss of neurofibromin alters adult metabolism via effects during a developmental critical period

Verdict. Neurofibromatosis type 1 (OMIM 162200) is a genetic disorder that results from mutations in the NF1 gene and its encoded neurofibromin protein (Nf1). It intersects mitochondrial stress/dysfunction themes (OXPHOS / ETC; disease context; systemic metabolic stress).

What the authors report

Metabolic alterations commonly accompany neurodevelopmental disorders and may contribute to their pathophysiology. The disorder is multisystemic, affecting multiple aspects of development, physiology, and brain function.

Key results stated in the abstract include the following. Neurofibromatosis type 1 (OMIM 162200) is a genetic disorder that results from mutations in the NF1 gene and its encoded neurofibromin protein (Nf1). Whether the metabolic alterations result from changes in neurodevelopment is not known. Here we approach this question in Drosophila melanogaster , which expresses a conserved NF1 gene, exhibits phenotypes reminiscent of the human disease, and shares key developmental mechanisms with humans.

Why it matters for mitochondrial biology

Within mitochondrial research, this work maps primarily to OXPHOS, redox biology, metabolism, neurobiology. It is relevant to mitochondrial dysfunction discourse because the abstract invokes OXPHOS / ETC, disease context, systemic metabolic stress. That does not by itself establish a validated disease mechanism; it indicates thematic proximity. OXPHOS/ETC involvement, if confirmed, would place the work in the core of bioenergetic pathophysiology rather than peripheral organelle biology. Server: biorxiv. Posted 2026-07-31. Synthesis confidence is bounded by abstract completeness.

Study design (abstract-level)

In addition, recent evidence suggests that Nf1 deficiency alters metabolic function in both humans and animal models. Flies with nf1 mutations or RNAi-mediated knockdown exhibit altered metabolism in adulthood.

Principal findings

1. Neurofibromatosis type 1 (OMIM 162200) is a genetic disorder that results from mutations in the NF1 gene and its encoded neurofibromin protein (Nf1).
2. Whether the metabolic alterations result from changes in neurodevelopment is not known.
3. Here we approach this question in Drosophila melanogaster , which expresses a conserved NF1 gene, exhibits phenotypes reminiscent of the human disease, and shares key developmental mechanisms with humans.
4. This suggests that the adult phenotype results from the onset of the developmental alteration during the critical period.
5. High-resolution respirometry on adult mitochondria revealed no differences in complex I/II function or fatty acid oxidation between nf1 mutants and controls, suggesting that the metabolic alterations localize upstream of the electron transport chain at the cellular level.

Limitations of this brief

• This Mitos brief is an abstract-level synthesis of a preprint; it is not peer review and not a substitute for reading the full paper.
• Preprint status: findings may change with revision or journal review.
• Effect sizes, n numbers, statistics, and full experimental controls are typically incomplete at abstract resolution.
• Primary source: biorxiv DOI 10.64898/2026.07.29.741559 (posted 2026-07-31).

Open scientific questions

• Which specific experimental panels in the full paper establish the strongest causal claim, and how robust are the controls?
• Are OXPHOS defects primary drivers or secondary consequences of broader cellular stress?
• Is the mitochondrial phenotype cell-autonomous in neurons/glia, or secondary to systemic/inflammatory signals?
• How do these findings sit relative to prior literature on the same pathway—replication, contradiction, or incremental extension?

Bottom line

For mitochondrial biologists focused on OXPHOS, redox biology, metabolism, this preprint is worth full-text review soon. Abstract-level takeaway: Neurofibromatosis type 1 (OMIM 162200) is a genetic disorder that results from mutations in the NF1 gene and its encoded neurofibromin protein (Nf1). Confirm methods, effect sizes, and controls in the full PDF before citing the result as established.

Bibliographic record

Abstract-based editorial synthesis by Mitos. Not peer review.